日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcome in Sarcoma

循环T细胞和肿瘤微环境特征与肉瘤免疫检查点阻断疗效的相关性

Rosenbaum, Evan; Ehrich, Fiona; Yosofvand, Mohammad; Bradic, Martina; Lee, Jasme; Adamow, Mathew; Movva, Sujana; Kelly, Ciara M; Avutu, Viswatej; Banks, Lauren B; Chan, Jason E; Chi, Ping; Dickson, Mark A; Gounder, Mrinal M; Keohan, Mary L; Maki, Robert G; Reed, Damon R; Fuentes, Paige; Collins, Paige; Desir, Rhoena; Reiner, Allison; Baranov, Oleg; Chernyshov, Konstantin; Kotlov, Nikita; Subramanian, Ajay; Moding, Everett J; Qin, Li-Xuan; Wong, Phillip; Tap, William D; Antonescu, Cristina R; Panageas, Katherine S; Shen, Ronglai; D'Angelo, Sandra P

Overall survival from the open-label phase II trial of palbociclib in patients with advanced well-differentiated/dedifferentiated liposarcoma

帕博西尼治疗晚期高分化/去分化脂肪肉瘤患者的开放标签 II 期试验的总生存期

Babatunde, O O; Seier, K; Schwartz, G; Keohan, M L; D'Angelo, S P; Gounder, M M; Chi, P; Antonescu, C R; Landa, J; Qin, L-X; Crago, A M; Singer, S; Koff, A; Tap, W D; Dickson, M A

Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma

CDK4/6 和 PD-1 序贯抑制后肿瘤和免疫动力学:一项去分化脂肪肉瘤 II 期研究的结果

Rosenbaum, Evan; Gularte-Mérida, Rodrigo; Seffar, Evan; Lee, Jasme; Adamow, Mathew; Bradic, Martina; Dickson, Mark A; Avutu, Viswatej; Banks, Lauren B; Chan, Jason E; Chi, Ping; Gounder, Mrinal M; Kelly, Ciara M; Keohan, Mary Louise; Maki, Robert G; Movva, Sujana; Reed, Damon R; Desir, Rhoena; Biniakewitz, Matthew; Erinjeri, Joseph P; Lefkowitz, Robert A; Wong, Phillip; Antonescu, Cristina R; Qin, Li-Xuan; Panageas, Katherine S; Shen, Ronglai; Singer, Samuel; Koff, Andrew; Tap, William D; D'Angelo, Sandra P

Duration of Initial Viremia Modulates Functional Properties of HIV-specific T Cell Receptors.

初始病毒血症持续时间调节 HIV 特异性 T 细胞受体的功能特性。

Ogunshola Funsho J, Singh Nishant K, Butty Vincent, Mishra Anurag R, Habte Zacharia, Vecchiarello Liza, Fahad Ahmed, Juergens Kate B, Cheever Sophia, Allombert Marius, Webber Anabelle, Piechocka-Trocha Alicja, Ismail Nasreen, Nathan Anusha, Li Xiaolong, Reddy Kavidha, Gounder Kamini, Baiyegunhi Omolara O, Collins David R, Ghebremichael Musie, Gaiha Gaurav, Dong Krista, Dekosky Brandon J, Ndung'u Thumbi, Birnbaum Michael E, Walker Bruce D

Duration of Initial Viremia Modulates Functional Properties of HIV-specific T Cell Receptors.

初始病毒血症持续时间调节 HIV 特异性 T 细胞受体的功能特性。

Ogunshola Funsho J, Singh Nishant K, Butty Vincent, Mishra Anurag R, Habte Zacharia, Vecchiarello Liza, Fahad Ahmed, Juergens Kate B, Cheever Sophia, Allombert Marius, Webber Anabelle, Piechocka-Trocha Alicja, Ismail Nasreen, Nathan Anusha, Li Xiaolong, Reddy Kavidha, Gounder Kamini, Baiyegunhi Omolara O, Collins David R, Ghebremichael Musie, Gaiha Gaurav, Dong Krista, Dekosky Brandon J, Ndung'u Thumbi, Birnbaum Michael E, Walker Bruce D

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas.

针对SMARCB1缺陷型肉瘤中PGBD5依赖性DNA损伤的表观遗传靶向治疗。

Kazansky Yaniv, Mueller Helen S, Cameron Daniel, Demarest Phillip, Zaffaroni Nadia, Arrighetti Noemi, Zuco Valentina, Mundi Prabhjot S, Kuwahara Yasumichi, Somwar Romel, Qu Rui, Califano Andrea, de Stanchina Elisa, Dela Cruz Filemon S, Kung Andrew L, Gounder Mrinal M, Kentsis Alex

Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma

rucaparib 和 nivolumab 治疗平滑肌肉瘤患者的 II 期研究

Sujana Movva ,Kenneth Seier ,Martina Bradic ,Karmelina Charalambous ,Evan Rosenbaum ,Ciara M Kelly ,Seth M Cohen ,Martee L Hensley ,Viswatej Avutu ,Lauren B Banks ,Jason E Chan ,Ping Chi ,Sandra D'Angelo ,Mark A Dickson ,Mrinal M Gounder ,Mary L Keohan ,Robert G Maki ,Angela Green ,Vicky Makker ,Maria M Rubinstein ,Sara Saunds ,Jae-Mun Cho ,Robert A Lefkowitz ,Joseph Erinjeri ,Li-Xuan Qin ,Ronak Shah ,Phillip Wong ,William Tap

Milademetan in Advanced Solid Tumors with MDM2 Amplification and Wild-type TP53: Preclinical and Phase II Clinical Trial Results

米拉德美坦治疗MDM2扩增和TP53野生型晚期实体瘤:临床前和II期临床试验结果

Dumbrava, Ecaterina E; Stinchcombe, Thomas E; Gounder, Mrinal; Cote, Gregory M; Hanna, Glenn J; Sumrall, Bradley; Wise-Draper, Trisha M; Kanaan, Mohammed; Duffy, Steven; Sumey, Christopher; Cobb, Patrick; Forbes, Andre; Beckmann, Aviva G; Schadt, Eric E; Ku, Nora; Tirunagaru, Vijaya G; Singh, Kanchan; Pei, Xinyu; Xu, Feng; Doebele, Robert C; Chen, Christopher T

A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma

一项针对晚期肉瘤患者的 I 期研究,评估 CSF1R 抑制剂 vimseltinib 与 PD-L1 抑制剂 avelumab 联合用药的疗效。

E Rosenbaum ,K Seier ,M Bradic ,S Movva ,C M Kelly ,M A Dickson ,M L Keohan ,M M Gounder ,P Chi ,B A Nacev ,J E Chan ,V Avutu ,M Biniakewitz ,S Jasnani ,M Duchemin ,R Desir ,P Wong ,J Erinjeri ,S Hwang ,C R Antonescu ,L-X Qin ,W D Tap ,S P D'Angelo

Bayesian estimation of HIV acquisition dates for prevention trials

利用贝叶斯方法估计预防试验中 HIV 感染日期

Raabya Rossenkhan,Elena E Giorgi,Danica Shao,James Ludwig,Phillip Labuschagne,Craig A Magaret,Thumbi Ndung'u ,Daniel Muema,Kamini Gounder,Krista L Dong,Bruce D Walker ,Morgane Rolland,Merlin L Robb,Leigh Anne Eller,Fredrick Sawe,Sorachai Nitayaphan,Eduard Grebe ,Michael P Busch,Kevin P Delaney,Shelley Facente ,Lindsay N Carpp,Allan C deCamp,Yunda Huang,Bette Korber,Michal Juraska,Erika Rudnicki,Ewelina Kosmider,Daniel B Reeves,Bryan T Mayer,John Hural,Wenjie Deng,Dylan H Westfall,Anna Yssel,David Matten,Tanmoy Bhattacharya,Lawrence Corey ,Peter B Gilbert ,Carolyn Williamson,James I Mullins ,Paul T Edlefsen